Proteomic analysis of psoriatic skin tissue for identification of differentially expressed proteins: Up-regulation of GSTP1, SFN and PRDX2 in psoriatic skin
Authors:
- Jae-We ChoJCJae-We Cho
- Byoung Chul ParkBPByoung Chul Park
- Kyu-Suk LeeKLKyu-Suk Lee
Open Access
- 25 July 2011
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 28 (5) , 785-792
Abstract
Psoriasis is a chronic inflammatory skin disease, characterized by a combination of abnormal proliferation of keratinocytes, immunology and vascular proliferation. Proteomic analyses have revealed some clues regarding the pathogenesis of psoriasis. In the present study, we conducted an investigation of different proteomes of psoriatic lesional skin, and compared them with those of normal and non-lesional psoriatic skin. We performed 2-D gel electrophoresis, liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis and database searches. Expression of proteins were evaluated by immunoblot and immunohistochemistry analyses. Our data showed differential expression of 74 and 145 protein spots in non-lesional and lesional psoriatic skin, respectively. Eleven of 36 proteins, which were identified by LC-MS/MS, were categorized as apoptosis-regulating proteins. Other protein spots were categorized as proteins with involvement in the negative regulation of apoptosis, defense response-related proteins and inflammatory response. Of particular interest, increased expression of glutathione S transferase 1 (GSTP1) and peroxiredoxin 2 (PRDX2), which are involved in the Redox balance system, and SFN, which is involved in the cellular proliferation system, was observed in psoriatic lesional skin. Localization of GSTP1 and SFN was observed above the middle layer of the epidermis in psoriatic skin lesions. Expression of PRDX2 was clearly observed below the middle layer of the epidermis in chronic type psoriatic skin lesions. Taken together, 36 identified proteins were associated with biological regulation, including regulation of cell death, defense response, inflammatory response and reactive oxygen species (ROS) regulation. PRDX2 and GSTP1 may play roles in compensating mechanisms for reduction of ROS stress, and SFN may play roles in prevention of cancer development in proliferating cells through G2/M cell cycle arrest upon accidental DNA damage within psoriatic skin lesions.Keywords
This publication has 15 references indexed in Scilit:
- Increased HIF‐1 alpha immunostaining in psoriasis compared to psoriasiform dermatitidesJournal of Cutaneous Pathology, 2009
- Oxidative stress in the pathogenesis of psoriasisFree Radical Biology and Medicine, 2009
- A comprehensive review of biomarkers in psoriasisClinical and Experimental Dermatology, 2009
- Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21Nature Genetics, 2009
- Detection of psoriasin/S100A7 in the sera of patients with psoriasisBritish Journal of Dermatology, 2009
- The histopathologic spectrum of psoriasisClinics in Dermatology, 2007
- Vegf is Likely a Key Factor in the Link between Inflammation and Angiogenesis in Psoriasis: Results of an Immunohistochemical StudyInternational Journal of Immunopathology and Pharmacology, 2006
- IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasisEuropean Journal of Immunology, 2006
- Antioxidant activity, lipid peroxidation and skin diseases. What's newJournal of the European Academy of Dermatology and Venereology, 2003
- Oxidative stress in keratinocytes as an etiopathogenetic factor of psoriasisBulletin of Experimental Biology and Medicine, 2000